Dynamic enoxaparin dosage in critical care patient with increased renal clearance

José Ángel Monsalve Naharro Servicio de Anestesia, Reanimación y Terapéutica del Dolor, Complejo Hospitalario Universitario de Albacete, Albacete
Manuel Gerónimo Pardo Servicio de Anestesia, Reanimación y Terapéutica del Dolor, Complejo Hospitalario Universitario de Albacete, Albacete
Beatriz Moreno Flores Servicio de Cirugía General, Complejo Hospitalario Universitario de Albacete, Albacete
Esther Domingo Chiva Servicio de Nefrología, Complejo Hospitalario Universitario de Albacete, Albacete
Pablo Cuesta Montero Servicio de Anestesia, Reanimación y Terapéutica del Dolor, Complejo Hospitalario Universitario de Albacete, Albacete
Marca Díaz Rangel Servicio de Farmacia, Complejo Hospitalario Universitario de Albacete, Albacete
Agustín Ortega Cerrato Servicio de Nefrología, Complejo Hospitalario Universitario de Albacete, Albacete

Keywords: Xa factor, drug monitoring, low-molecular weight heparin, enoxaparin, venous thromboembolism, critical care

References

Udy AA, Baptista JP, Lim NL, Joynt GM, Jarrett P, Wockner L, et al. Augmented renal clearance in the ICU: results of a multicenter observational study of renal function in critically ill patients with normal plasma creatinine concentrations. Crit Care Med. 2014;42(3):520-7.

Fuster-Lluch O, Gerónimo-Pardo M, Peyró-García R, Lizán-García M. Glomerular hyperfiltration and albuminuria in critically ill patients. Anaesth Intensive Care. 2008;36(5):674-80.

Hobbs AL, Shea KM, Roberts KM, Daley MJ. Implications of Augmented Renal Clearance on Drug Dosing in Critically Ill Patients: A Focus on Antibiotics. Pharmacotherapy. 2015;35(11):1063-75.

Claus BO, Hoste EA, Colpaert K, Robays H, Decruyenaere J, De Waele JJ. Augmented renal clearance is a common finding with worse clinical outcome in critically ill patients receiving antimicrobial therapy. J Crit Care. 2013;28(5):695-700.

Manresa Ramón N, Nájera Pérez MD, Page del Pozo MÁ, Sánchez Martínez I, Sánchez Catalicio Mdel M, Roldán Schilling V. Establecimiento de un protocolo para el uso de la heparina en pacientes con características especiales. Farm Hosp. 2014;38(2):135-44.

Lim W, Meade M, Lauzier F, Zarychanski R, Mehta S, Lamontagne F, et al. Failure of anticoagulant thromboprophylaxis: risk factors in medical-surgical critically ill patients. Crit Care Med. 2015;43(2):401-10.

Robinson S, Zincuk A, Strøm T, Larsen TB, Rasmussen B, Toft P. Enoxaparin, effective dosage for intensive care patients: double-blinded, randomised clinical trial. Crit Care. 2010;14(2):R41.

Malinoski D, Jafari F, Ewing T, Ardary C, Conniff H, Baje M, et al. Standard prophylactic enoxaparin dosing leads to inadequate anti-Xa levels and increased deep venous thrombosis rates in critically ill trauma and surgical patients. J Trauma. 2010;68(4):874-80.

De Waele JJ, Dumoulin A, Janssen A, Hoste EA. Epidemiology of augmented renal clearance in mixed ICU patients. Minerva Anestesiol. 2015;81(10):1079-85.

Minville V, Asehnoune K, Ruiz S, Breden A, Georges B, Seguin T, et al. Increased creatinine clearance in polytrauma patients with normal serum creatinine: a retrospective observational study. Crit Care. 2011;15(1):R49.

Herrera-Gutiérrez ME, Seller-Pérez G, Banderas-Bravo E, Muñoz-Bono J, Lebrón-Gallardo M, Fernandez-Ortega JF. Replacement of 24-h creatinine clearance by 2-h creatinine clearance in intensive care unit patients: a single-center study. Intensive Care Med. 2007;33(11):1900-6.

Ruiz S, Minville V, Asehnoune K, Virtos M, Georges B, Fourcade O, et al. Screening of patients with augmented renal clearance in ICU: taking into account the CKD-EPI equation, the age, and the cause of admission. Ann Intensive Care. 2015;5(1):49.

Pea F, Viale P. Bench-to-bedside review: Appropriate antibiotic therapy in severe sepsis and septic shock--does the dose matter? Crit Care. 2009;13(3):214.

Singer GA, Riggi G, Karcutskie CA, Vaghaiwalla TM, Lieberman HM, Ginzburg E, et al. Anti-Xa Guided Enoxaparin Thromboprophylaxis Reduces Rate Of Deep Venous Thromboembolism In High-Risk Trauma Patients. J Trauma Acute Care Surg. J Trauma Acute Care Surg. 2016;81(6):1101-08.

Vincent PD, Albert M, Champagne MC, Zikos T, Boulanger I, Blais L, et al. Factors influencing enoxaparin anti-Xa activity in surgical critically ill patients. J Crit Care. 2011;26(4):347-51.

Published

2017-09-04

How to Cite

Monsalve Naharro J Ángel, Pardo MG, Moreno Flores B, Chiva ED, Cuesta Montero P, Díaz Rangel M, Ortega Cerrato A. Dynamic enoxaparin dosage in critical care patient with increased renal clearance. Rev Nefrol Dial Traspl. [Internet]. 2017Sep.4 [cited 2024Dec.22];37(3):167-71. Available from: http://revistarenal.org.ar/index.php/rndt/article/view/187